健保藥品HTA評估報告
| 序號 | 標題 | 檔案類型 |
|---|---|---|
| 381 | Remsima Solution for Injection |
|
| 382 | 泰時維膜衣錠 (Ayvakit film-coated tablets) |
|
| 383 | 維萬心軟膠囊 (Vyndamax) |
|
| 384 | 利腸服注射劑 (Revestive injection) |
|
| 385 | EYBELIS ophthalmic solution |
|
| 386 | Chenodexycholic acid |
|
| 387 | Berinert |
|
| 388 | Demylocan lyophilized powder for injection |
|
| 389 | 達珂凍晶注射劑 (Dacogen® Powder for Concentrate for Solution for Infusion) |
|
| 390 | Rinvoq Extended-Release Tablets 15 mg |
|
| 391 | 修訂重度持續性氣喘治療藥品omalizumab 成分藥品(如Xolair)及嗜伊紅性(嗜酸性)白血球的嚴重氣喘治療藥品mepolizumab(如Nucala)、benralizumab(如Fasenra) |
|
| 392 | Xeljanz Film-Coated Tablets 5 mg、Xeljanz XR Extended Release Tablets 11 mg |
|
| 393 | Jyseleca 100 mg and 200 mg film-coated tablets |
|
| 394 | Evrysdi |
|
| 395 | Spinraza Solution for injection |
|
| 396 | PhosAdd Tab. |
|
| 397 | 克瘤康膠囊 (Calquence Capsules) |
|
| 398 | 德邁特膜衣錠 (TEPMETKO) |
|
| 399 | Evrysdi Powder for Oral Solution, 0.75 mg/ml |
|
| 400 | Galafold |
|